Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
filingDate |
2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1918291-A1 |
titleOfInvention |
3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
abstract |
The present invention relates to pyrazolo[1,5-a]pyrimidine-3-carboxylic acid compounds of formula In nor pharmaceutically acceptable salts thereof and their use for the treatment of protein kinase modulation responsive diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017178416-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130768-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10934301-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001590-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604525-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017251155-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I742067-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180134966-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2769448-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018197401-A1 |
priorityDate |
2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |